Lack of HLH in FMF

Ozge Basaran1, Erdal Sag1,2, Elif Arslanoglu Aydın3

  • 1Department of Pediatric Rheumatology, Hacettepe University, 06230, Altındag, Ankara, Turkey.

Abstract

Insights

Macrophage activation syndrome (MAS) in systemic juvenile idiopathic arthritis (sJIA) involves heightened interferon-gamma (IFN-γ) responses. This enhanced IFN-γ responsiveness distinguishes MAS patients from Familial Mediterranean Fever (FMF) patients, potentially explaining why MAS is rare in FMF.

Area of Science:

  • Immunology
  • Rheumatology
  • Genetics

Background:

  • Macrophage activation syndrome (MAS) is a severe complication of systemic juvenile idiopathic arthritis (sJIA).
  • MAS involves excessive T cell and macrophage activation, leading to a cytokine storm with key roles for interferon-gamma (IFN-γ) and IL-18.
  • Familial Mediterranean Fever (FMF) is an autoinflammatory disease characterized by recurrent fevers, but MAS is rare in FMF patients despite inflammation.

Purpose of the Study:

  • To compare the in vitro responsiveness of peripheral blood mononuclear cells (PBMCs) to IFN-γ between patients with sJIA/MAS and FMF.
  • To investigate the role of IFN-γ-induced chemokines and IL-18 in differentiating these conditions.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) were isolated from five sJIA/MAS patients and five FMF patients.
  • PBMCs were stimulated in vitro with IFN-γ.
  • Levels of IFN-γ-induced chemokines (CXCL9, CXCL10) and IL-18 were measured before and after stimulation using cytometric bead arrays.

Main Results:

  • PBMCs from MAS patients exhibited higher baseline CXCL9 levels compared to FMF patients during a flare.
  • IFN-γ stimulation significantly increased CXCL9 levels in MAS patients compared to FMF patients.
  • IFN-γ stimulation upregulated IL-18 production in MAS patients but not in FMF patients.

Conclusions:

  • Enhanced in vitro responsiveness to IFN-γ is a distinguishing feature of sJIA/MAS patients compared to FMF patients.
  • This heightened IFN-γ sensitivity in MAS may contribute to the lower incidence of MAS in FMF.
  • Understanding these differential responses could inform therapeutic strategies for MAS.

Related Concept Videos

Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
14.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
53.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
124